Hyderabad, Feb 6 :

Hyderabad-based Celon Laboratories Limited, a fully integrated specialty biopharmaceutical company, today announced the launch of its fifth division ‘Healon’.

Healon is a multispecialty division with robust product basket comprising antibiotics, pain management, astro- intestinal, cough and cold and nutraceuticals, a company release said here today.

The release aid the new division targets to achieve a part of Rs 2,500 crore market existing in India by adding around 1,000 people to its field force.

With this foray, the company envisages a turnover of Rs 250 crore by the end of FY 2013, the release said.

(UNI)

source: http://www.NewKerala.com / Home> News> Pharmaceutical-News / February 06th, 2012